07.20.09 | Paul M. Rivard discusses the CAFC’s decision to grant a rehearing in Tafas v. Doll.

Mr. Rivard comments on the Fed Circuit’s decision to rehear Tafas v. Doll in FDA News and Managing Intellectual Property.  Mr. Rivard addresses how this decision will impact the pharmaceutical industry.